News
News from Holden
Filter by:
Holden is one of three U.S. centers offering the latest radiation therapy technology.
The UI Department of Radiation Oncology this month began using a just-approved radiation therapy device that combines state-of-the-art imaging and radiation targeting. Holden Comprehensive Cancer Center is only the third center in the country offering this technology.
Patients helped design new cellular therapy unit.
The spacious new Stem Cell Transplant and Cellular Therapies Unit was designed with help from patients to make comfort and convenience a top priority,
There’s help for cancer patients to quit smoking.
Holden researchers receive NCI grant to improve smoking cessation interventions for current cancer patients.
Sarcoma outcomes improve at high-volume centers.
Sarcoma patients treated at high-volume medical centers may have higher survival rates than those treated at low-volume centers.
Holden announces CAR T-cell therapy.
Holden is now certified to offer CAR T-cell therapy, a newly approved treatment that uses a patient’s own white blood cells to detect and kill cancer cells.
Hawkeyes and Cyclones work side by side in unique cancer research project.
Cancer researchers at two Iowa universities are collaborating on research to address cancer similarities in humans and their companion animals.
The incidence of HPV cancers is increasing in Iowa.
While the overall number of new cancer cases in Iowa remains mostly unchanged, the number of cancers related to the human papillomavirus (HPV) is on the rise.
Study suggests new approach to treating kids with relapsed cancer.
The study’s findings may provide insight on new approaches or combination therapies to improve other forms of chemotherapy and limit side effects.